Expression of an Immunomodulatory Protein Known as Progesterone Induced Blocking Factor (PIBF) Does Not Correlate With First Trimester Spontaneous Abortions in Progesterone Supplemented Women

Authors

  • Dr. Jerome H. Check,

    Corresponding author
    1. The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology and Infertility, Camden, New Jersey
    Search for more papers by this author
  • Adam Ostrzenski,

    1. Department of Obstetrics and Gynecology, Howard University College of Medicine, Washington, D.C.
    Search for more papers by this author
  • Rudolf Klimek

    1. Department of Obstetrics and Gynecology, Jagiellonian University College of Medicine, Krakow, Poland
    Search for more papers by this author

7447 Old York Road, Melrose Park, PA 19027.

Abstract

PROBLEM: An immunomodulatory protein known as the progesterone induced blocking factor (PIBF) has been found to positively correlate with early pregnancy beta human chorionic gonadotropin (B-hCG) levels. The study presented herein evaluated PIBF levels from conception to the end of the first trimester to determine if lower levels will correlate with first trimester spontaneous abortions (SAB).

METHOD: Progesterone induced blocking factor expression by lymphocytes measured using an immunocytochemistry method was compared in pregnant women with ongoing vs. failed pregnancies.

RESULTS: There were no differences in the proportion of women having lymphocytes expressing PIBF or in the median numbers when comparing ongoing vs. failed pregnancies. There was no B-hCG interval where failed pregnancies were found to have lower frequency of PIBF expressing lymphocytes.

CONCLUSION: Inadequate PIBF expression independent of low P levels does not appear to be an etiologic factor for first trimester SABs; thus measuring this protein in pregnant women lacks practical usefulness.

Ancillary